FundedIQ
Biotechnology

Pacific Edge: Funding, Investors & Team (Sep 2026)

Pacific Edge is a cancer diagnostics company. They specialise in discovering, building and commercialising innovative cancer diagnostic tests that can contribute to a clinically meaningful difference in the detection and management of cancer. Their products are built from their proprietary genetic databases, which are used to identify diagnostic and prognostic biomarkers for cancer.

www.pacificedgedx.com LinkedIn Dunedin, New Zealand 101-250 employees
Biopharma Biotechnology Health Diagnostics Life Science
Total raised
$15.1M
Rounds
1
Latest
Undisclosed round
May 2026

Pacific Edge has raised $15.1M across 1 funding round on record, the most recent an undisclosed round of $15.1M announced in May 2026.

That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Pacific Edge Company Profile and Key Stats

Total funding raised
$15.1M
across 1 round on record
Funding rounds on record
1
Latest funding round
Undisclosed round
$15.1M in May 2026
Employees
101-250
reported band
Headquarters
Dunedin, New Zealand

Latest funding round on record: May 2026.

Pacific Edge Funding Rounds

Date
Round
Amount
Undisclosed round
$15.1M

Pacific Edge Founders and Leadership Team

Name
Role
Contact
Peter Meintjes
Founder
Locked

Contact details for the Pacific Edge team: 1 has a LinkedIn profile.

Start 14-day free trial →

Pacific Edge Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,179
$8.0M
126
$4.7M

Pacific Edge's latest round of $15.1M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Pacific Edge in Biotechnology and Dunedin

Companies Similar to Pacific Edge

Pictor is an in-vitro diagnostics company that offers a patented multiplexed platform for highly accurate and…

Undisclosed round $7.5M

Scentian Bio functions as a platform that offers a comprehensive sensing solution.

Seed $7.0M

Algorae Pharmaceuticals is an Australasian biotechnology company working on AI-enhanced drug research and…

Undisclosed round $2.3M

Mars Bioimaging Ltd (MBI) was formed in 2007 to commercialise the ground-breaking MARS imaging system for its…

Series A $15.0M
Seed $720k

Alimetry is a health technology startup based in Auckland, New Zealand, developing breakthrough solutions for…

Series A $18.0M

Jooules provides a sustainable food solution that promotes a more environmentally friendly and healthier…

Pre-Seed $590k

Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…

Convertible Note $6.8M

MAASH is a biotech mycoprotein producing company that supply a nutritious and health feed and food protein…

Seed $6.8M

XiltriX North America is an information technology company that specializes in monitoring, predictive…

Undisclosed round $3.0M

Adaptyv Biosystems developing a protein engineering platform using cell-free synthetic biology and…

Series A $40.0M

Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…

Seed $3.1M

Pacific Edge Funding FAQs

What does Pacific Edge do?

Pacific Edge is a cancer diagnostics company. They specialise in discovering, building and commercialising innovative cancer diagnostic tests that can contribute to a clinically meaningful difference in the detection and management of cancer. Their products are built from their proprietary genetic databases, which are used to identify diagnostic and prognostic biomarkers for cancer.

How much funding has Pacific Edge raised?

Pacific Edge has raised $15.1M across 1 round on record. The most recent is an undisclosed round of $15.1M announced in May 2026.

When did Pacific Edge last raise funding?

Pacific Edge's most recent funding round on record is an undisclosed round of $15.1M, announced in May 2026.

Who founded Pacific Edge?

FundedIQ lists Peter Meintjes (Founder) at Pacific Edge.

Where is Pacific Edge headquartered?

Pacific Edge is based in Dunedin, Otago, New Zealand.

How many employees does Pacific Edge have?

Pacific Edge is in the 101-250 employee band.

How does Pacific Edge's funding compare to other Biotechnology startups?

Pacific Edge's latest round of $15.1M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.

About FundedIQ's Pacific Edge Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Pacific Edge is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.